| Financial Year |
March 31 2023 |
| Monetary Funds |
382,809,574.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
9,605,411.69 |
| Advances to Suppliers |
1,057,756.31 |
| Other Receivables |
2,426,805.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
19,987,784.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
877,071.62 |
| Total Current Assets |
416,764,404.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,176,010.07 |
| Investment Properties |
14,047.96 |
| Fixed Assetes |
39,773,328.17 |
| Under-construction Projects |
156,155,803.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
73,487,695.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
128,358.35 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
315,935,244.35 |
| Total Assets |
732,699,648.65 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,011,615.47 |
| Accounts Payable |
14,211,269.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,732,551.17 |
| Taxes Payable |
796,123.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
-- |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
35,027.35 |
| Sub-Total of Current Liabilities |
21,418,812.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
232,126.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,261,752.08 |
| Total Liabilities |
23,680,564.77 |
| Paid-In Capital(Or Share Stock) |
70,000,000.00 |
| Capital Surplus |
491,946,572.17 |
| Surplus Reserve |
32,405,609.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
114,666,902.63 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
709,019,083.88 |
| Owner's Equity（Stockholder's Equity） |
709,019,083.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
732,699,648.65 |
